• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT VASCULAR STENT; VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT VASCULAR STENT; VASCULAR STENT SYSTEM Back to Search Results
Catalog Number EX060603C
Device Problems Difficult to Advance (2920); Positioning Problem (3009)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/29/2020
Event Type  malfunction  
Manufacturer Narrative
The catalog number identified has not been cleared in the us but is similar to the lifestent stent system products that are cleared in the us.The pro code and 510k number for the lifestent stent system products is identified.As the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.Expiry date (04/2022).
 
Event Description
It was reported that during a stent placement procedure through the right hepatic vein, the device allegedly felt resistance while being inserted.It was further reported that the stent failed to reach the desired lesion.The procedure was completed by closing the collateral vessel.There was no reported patient injury.
 
Manufacturer Narrative
H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.No additional complaint has been previously reported for this lot number.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.A review of manufacturing records was not performed.Investigation summary: the sample was returned to the manufacturer for evaluation.Based on the evaluation of the returned delivery system the reported problem to reach the target lesion could not be reproduced.No device deficiencies that may have contributed to the issues experienced by the customer could be identified.Potential factors that could have led or contributed to the reported event have been evaluated.Therefore, previous investigations of similar complaints have been reviewed.The reported difficulties to advance the delivery system to the target lesion may be related to a difficult patient anatomy or challenging placement site.Inappropriate accessories used or not performed pre dilation may be contributing factors.In this case the reported indication of a tips procedure (transjugular intrahepatic portosystemic shunt) represents an off label use of the device.Based on the evaluation of the returned delivery system the reported problem to reach the target lesion could not be reproduced.No device deficiencies that may have contributed to the issues experienced by the customer could be identified.Based on the information available a definite root cause for the reported event could not be determined.Labeling review: in reviewing the current labeling for this product the potential issue was found addressed.The instruction for use states: "if resistance is met during stent system introduction, the stent system should be removed and another stent system should be used." regarding indications for use the instruction for use states: "the lifestent® vascular stent is intended for primary stenting of de-novo or restenotic lesions of the peripheral arteries." the intended use of the device during a tips procedure represents an off label use of the device.H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the lifestent vascular stent products that are cleared in the us.The pro code and 510k number for the lifestent vascular stent products is identified in d2 and g4.H10: d4 (expiry date: 04/2022), g3.H11: h6 (method, result, conclusion).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that during a stent placement procedure through the right hepatic vein, the device allegedly felt resistance while being inserted.It was further reported that the stent failed to reach the desired lesion.The procedure was completed by closing the collateral vessel.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT VASCULAR STENT
Type of Device
VASCULAR STENT SYSTEM
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
MDR Report Key10903863
MDR Text Key219529087
Report Number9681442-2020-20046
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P070014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberEX060603C
Device Lot NumberANER0614
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/09/2020
Initial Date Manufacturer Received 10/29/2020
Initial Date FDA Received11/25/2020
Supplement Dates Manufacturer Received05/27/2021
Supplement Dates FDA Received05/31/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age65 YR
-
-